What does dyspareunia mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What Dyspareunia Means

Dyspareunia is genital or pelvic pain that occurs before, during, or after sexual intercourse 1, 2, 3.

Clinical Definition and Classification

Dyspareunia is classified based on two key characteristics:

Location of Pain

  • Superficial dyspareunia: Pain occurs during vaginal penetration or at the vaginal entrance 4, 3
  • Deep dyspareunia: Pain appears in the lower abdomen or deeper within the vagina 4, 5

Timing of Onset

  • Primary dyspareunia: Pain present from first sexual experience
  • Secondary dyspareunia: Pain develops after a period of pain-free intercourse 5

Clinical Significance

The pain characteristics vary considerably:

  • Quality: Can range from dull to sharp 2
  • Pattern: May be intermittent or continuous 2, 5
  • Duration: Can be recurrent or persistent 3

Prevalence and Impact

Dyspareunia affects 10-28% of women during their lifetime 4, 3, making it the most commonly diagnosed form of female sexual dysfunction 1. The condition significantly impacts:

  • Quality of life 4, 3
  • Sexual function and relationship satisfaction 2, 3
  • Mental health (increased risk of anxiety and depression) 3
  • Self-esteem and confidence 2

Clinical Context

A critical caveat: Many women are reluctant to report dyspareunia symptoms to healthcare providers, making it an underreported condition 2. The responsibility falls on clinicians to create safe environments where patients feel comfortable discussing sexual health concerns 2, 3.

The term appears frequently in treatment guidelines for genitourinary syndrome of menopause (GSM), where dyspareunia is a cardinal symptom treatable with local low-dose vaginal estrogen, vaginal DHEA, or ospemifene 6. In cancer survivors, dyspareunia management includes topical vaginal therapies, pelvic physical therapy, and topical anesthetics 7.

References

Research

High Comorbidity of Gastrointestinal Disorders Among Those Seeking Care for Dyspareunia.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2024

Research

Dyspareunia: Etiology, presentation, and management.

The Nurse practitioner, 2023

Research

Dyspareunia in Women.

American family physician, 2021

Research

The clinical anatomy of dyspareunia: A review.

Clinical anatomy (New York, N.Y.), 2018

Guideline

sexual function in cancer survivors: updates to the nccn guidelines for survivorship.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.